RT Journal Article
SR Electronic
T1 An acceptable method to evaluate the analytical performance of real-time fluorescent RT-PCR targeting SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.18.20105247
DO 10.1101/2020.05.18.20105247
A1 Ren, Xiao-Dong
A1 Tang, Qi-Mei
A1 Chen, Min
A1 Huang, Qian
A1 Huang, Heng-Liu
A1 Wang, Liu
A1 Su, Ning
A1 Sun, Xian-Ge
A1 Wei, Kun
A1 Lu, Wei-Ping
A1 Deng, Shao-Li
A1 Huang, Qing
YR 2020
UL http://medrxiv.org/content/early/2020/05/21/2020.05.18.20105247.abstract
AB It was necessary to carry out methodologies evaluations of real-time fluorescent reverse-transcription PCR (RT-PCR) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Considering biosafety issues and lack of positive specimens in some special locations in China, the routine specimens from healthy individuals were used to perform methodologies evaluations, in which the indexes were the differences of quantification cycle values (Δ Cq) between human derived internal reference control (IRC) genes of a specimen and quality control (QC). Serial experiments were carried out to evaluate various factors that might affect aforementioned methodologies, such as types of virus transport mediums, methods of specimen pretreatment and template preparation, specimen vortex strength, specimen storage temperature and duration. The results showed that using ΔCq values as indexes, among various factors that might affect analytical performance, it was better to store specimens in the normal saline transport mediums, inactivate pathogens using water or metal bath, release more virus particles from swabs by vortex mixing, extract nucleic acids with centrifuge methods, and perform amplification assays timely. Aforementioned opinions and optimum conditions were further confirmed by SRAS-CoV-2 pseudovirus and clinical positive specimens. Altogether, the results of this study indicated that the routine specimens from healthy individuals could be used to evaluate the analytical performance of real-time fluorescent RT-PCR targeting SRAS-CoV-2, of which the indexes were the ΔCq values between IRC genes of a specimen and QC. This acceptable method was extremely valuable in both theoretical and practical significance under current pandemic of coronavirus disease 2019 (COVID-19).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partly supported by the 2019-nCoV Emergency Research Project (No. CWS20C008), the Military Logistics Scientific Research Project (No. 2019HQZX06), the Military Medical Frontier Innovation Ability Training Program (No. 2019CXJSB005) and University Outstanding Talent Support Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data generated or analyzed during this study are included in this article.